Biblio

Export 244 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Keyword is I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N
M. Frenkel-Pinter, Tal, S., Scherzer-Attali, R., Abu-Hussien, M., Alyagor, I., Eisenbaum, T., Gazit, E., and Segal, D., Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity., J Alzheimers Dis, vol. 51, no. 1, pp. 165-78, 2016.
M. El Haj, Coello, Y., Kapogiannis, D., Gallouj, K., and Antoine, P., Negative Prospective Memory in Alzheimer's Disease: "Do Not Perform That Action"., J Alzheimers Dis, vol. 61, no. 2, pp. 663-672, 2018.
M. Fotuhi, Mian, A., Meysami, S., and Raji, C. A., Neurobiology of COVID-19., J Alzheimers Dis, vol. 76, no. 1, pp. 3-19, 2020.
L. Calderón-Garcidueñas, Kavanaugh, M., Block, M., D'Angiulli, A., Delgado-Chávez, R., Torres-Jardón, R., González-Maciel, A., Reynoso-Robles, R., Osnaya, N., Villarreal-Calderon, R., Guo, R., Hua, Z., Zhu, H., Perry, G., and Diaz, P., Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults., J Alzheimers Dis, vol. 28, no. 1, pp. 93-107, 2012.
E. G. McGeer and McGeer, P. L., Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy., J Alzheimers Dis, vol. 19, no. 1, pp. 355-61, 2010.
R. Lizio, Del Percio, C., Marzano, N., Soricelli, A., Yener, G. G., Başar, E., Mundi, C., De Rosa, S., Triggiani, A. Ivano, Ferri, R., Arnaldi, D., Nobili, F. Mariano, Cordone, S., Lopez, S., Carducci, F., Santi, G., Gesualdo, L., Rossini, P. M., Cavedo, E., Mauri, M., Frisoni, G. B., and Babiloni, C., Neurophysiological assessment of Alzheimer's disease individuals by a single electroencephalographic marker., J Alzheimers Dis, vol. 49, no. 1, pp. 159-77, 2016.
M. Van Zeller, Dias, D., Sebastião, A. M., and Valente, C. A., NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease., J Alzheimers Dis, vol. 83, no. 3, pp. 939-961, 2021.
M. Van Zeller, Dias, D., Sebastião, A. M., and Valente, C. A., NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease., J Alzheimers Dis, vol. 83, no. 3, pp. 939-961, 2021.
H. B. Allen, A Novel Approach to the Treatment and Prevention of Alzheimer's Disease Based on the Pathology and Microbiology., J Alzheimers Dis, vol. 84, no. 1, pp. 61-67, 2021.
M. Fà, Zhang, H., Staniszewski, A., Saeed, F., Shen, L. W., Schiefer, I. T., Siklos, M. I., Tapadar, S., Litosh, V. A., Libien, J., Petukhov, P. A., Teich, A. F., Thatcher, G. R. J., and Arancio, O., Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 3, pp. 707-21, 2016.
O
H. Sandison, Callan, N. G. L., Rao, R. V., Phipps, J., and Bradley, R., Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline., J Alzheimers Dis, vol. 94, no. 3, pp. 993-1004, 2023.
C. Lange, Suppa, P., Frings, L., Brenner, W., Spies, L., and Buchert, R., Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion., J Alzheimers Dis, vol. 49, no. 4, pp. 945-59, 2016.
P. Banerjee, Sahoo, A., Anand, S., Bir, A., and Chakrabarti, S., The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 3, pp. 681-93, 2016.
P. Banerjee, Sahoo, A., Anand, S., Bir, A., and Chakrabarti, S., The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 3, pp. 681-93, 2016.
M. L. Croze and Zimmer, L., Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms., J Alzheimers Dis, vol. 62, no. 2, pp. 503-522, 2018.
M. L. Croze and Zimmer, L., Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms., J Alzheimers Dis, vol. 62, no. 2, pp. 503-522, 2018.
P
A. Malara, De Biase, G. Andrea, Bettarini, F., Ceravolo, F., Di Cello, S., Garo, M., Praino, F., Settembrini, V., Sgrò, G., Spadea, F., and Rispoli, V., Pain Assessment in Elderly with Behavioral and Psychological Symptoms of Dementia., J Alzheimers Dis, vol. 50, no. 4, pp. 1217-25, 2016.
J. J. Iliff, Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., G Vates, E., Deane, R., Goldman, S. A., Nagelhus, E. A., and Nedergaard, M., A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β., Sci Transl Med, vol. 4, no. 147, p. 147ra111, 2012.
S. Aasish Roshan, Elangovan, G., Gunaseelan, D., Jayachandran, S. K., Kandasamy, M., and Anusuyadevi, M., Pathogenomic Signature and Aberrant Neurogenic Events in Experimental Cerebral Ischemic Stroke: A Neurotranscriptomic-Based Implication for Dementia., J Alzheimers Dis, vol. 94, no. s1, pp. S289-S308, 2023.
S. Aasish Roshan, Elangovan, G., Gunaseelan, D., Jayachandran, S. K., Kandasamy, M., and Anusuyadevi, M., Pathogenomic Signature and Aberrant Neurogenic Events in Experimental Cerebral Ischemic Stroke: A Neurotranscriptomic-Based Implication for Dementia., J Alzheimers Dis, vol. 94, no. s1, pp. S289-S308, 2023.
Y. Moon, Han, S. - H., and Moon, W. - J., Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging., J Alzheimers Dis, vol. 51, no. 3, pp. 737-45, 2016.
Y. Moon, Han, S. - H., and Moon, W. - J., Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging., J Alzheimers Dis, vol. 51, no. 3, pp. 737-45, 2016.
A. F. Teich, Sakurai, M., Patel, M., Holman, C., Saeed, F., Fiorito, J., and Arancio, O., PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease., J Alzheimers Dis, vol. 52, no. 1, pp. 295-302, 2016.
L. Wang, Chen, H., Tang, J., Guo, Z., and Wang, Y., Peptidylarginine Deiminase and Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 473-484, 2022.
P. Suppa, Hampel, H., Kepp, T., Lange, C., Spies, L., Fiebach, J. B., Dubois, B., and Buchert, R., Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment., J Alzheimers Dis, vol. 51, no. 3, pp. 867-73, 2016.

Pages